insights_auto
Why is ENOV up 5.18%?
Dive Deeperchevron_right
ENOV:NYSE
Enovis Corp
$18.69
arrow_upward
+5.18%(+0.92) 1D
$18.70
arrow_upward
+0.05% (+0.010)todayPre-market
Closed: Oct 5, 4:00:06 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ENOV...
Open
$17.70
High
$18.96
Low
$17.56
Mkt. cap
1.08B
Avg. vol.
1.80M
Volume
6.03K
52-wk high
$34.28
52-wk low
$17.30
EPS
-$19.27
Beta
1.14
Shares outstanding
57.67M
No. of employees
8K
Open
$17.70
High
$18.96
Low
$17.56
Mkt. cap
1.08B
Avg. vol.
1.80M
Volume
6.03K
52-wk high
$34.28
52-wk low
$17.30
EPS
-$19.27
Beta
1.14
Shares outstanding
57.67M
No. of employees
8K
News stories
From web sources and news partners
Investing.com
·
20 hours ago
UBS cuts Enovis stock price target on acquisition impact
Profile
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Dallas, Texas and is listed on the NYSE as ENOV. The company has over 8,000 employees operating at 30 sites around the world. Wikipedia
About Enovis Corp
CEOMatthew L. Trerotola
Employees7.8K
Founded1995
HeadquartersWilmington, Delaware, United States
SectorMedical device
Websiteenovis.com